[Clinical significance of lysosomal enzyme activity determination in peripheral blood].
D002403:Cathepsins / Q000097:blood; D005260:Female; D005966:Glucuronidase / Q000097:blood; D006506:Hepatitis A / Q000201:enzymology; D006596:Hexosaminidases / Q000097:blood; D006801:Humans; D007239:Infections / Q000097:blood / Q000201:enzymology*; D007244:Infectious Mononucleosis / Q000201:enzymology; D008206:Lymphatic Diseases / Q000201:enzymology; D008214:Lymphocytes / Q000201:enzymology*; D008247:Lysosomes / Q000201:enzymology*; D008297:Male; D009196:Myeloproliferative Disorders / Q000201:enzymology; D010744:Phosphoric Monoester Hydrolases / Q000097:blood; D011247:Pregnancy
D010744:Phosphoric Monoester Hydrolases; D006596:Hexosaminidases; D005966:Glucuronidase; D002403:Cathepsins
Kliniczne znaczenie oznaczania aktywności enzymów lizosomalnych limfocytów krwi obwodowej